Antibiotics-Basel

metrics 2024

Leading the charge in antibiotic solutions and therapeutic advancements.

Introduction

Antibiotics-Basel is a prestigious multidisciplinary journal published by MDPI, dedicated to advancing the field of antibiotic research and management. Since its inception in 2012 as an Open Access publication, the journal has established itself as a vital resource for researchers and professionals, offering an accessible platform for the dissemination of innovative findings in Biochemistry, Infectious Diseases, Microbiology, and Pharmacology. With a solid impact in its category, Antibiotics-Basel holds a Q1 ranking in critical areas such as Pharmacology and Pharmacology, Toxicology and Pharmaceutics, making it an influential journal in its field. The journal publishes high-quality research articles, reviews, and communications that are essential for advancing our understanding of antibiotic mechanisms, resistance, and therapeutic applications. Researchers are invited to submit their manuscript to contribute to this growing body of knowledge and collaborate in the fight against antibiotic resistance and infectious diseases.

Metrics 2024

SCIMAGO Journal Rank0.92
Journal Impact Factor4.30
Journal Impact Factor (5 years)4.60
H-Index77
Journal IF Without Self4.30
Eigen Factor0.03
Normal Eigen Factor7.02
Influence0.84
Immediacy Index1.20
Cited Half Life2.40
Citing Half Life6.50
JCI1.06
Total Documents6618
WOS Total Citations24141
SCIMAGO Total Citations45606
SCIMAGO SELF Citations5029
Scopus Journal Rank0.92
Cites / Document (2 Years)4.45
Cites / Document (3 Years)4.80
Cites / Document (4 Years)4.85

Metrics History

Rank 2024

Scopus

General Pharmacology, Toxicology and Pharmaceutics in Pharmacology, Toxicology and Pharmaceutics
Rank #5/80
Percentile 93.75
Quartile Q1
Pharmacology (medical) in Medicine
Rank #47/272
Percentile 82.72
Quartile Q1
Infectious Diseases in Medicine
Rank #83/344
Percentile 75.87
Quartile Q1
Biochemistry in Biochemistry, Genetics and Molecular Biology
Rank #130/438
Percentile 70.32
Quartile Q2
Microbiology (medical) in Medicine
Rank #46/140
Percentile 67.14
Quartile Q2
Microbiology in Immunology and Microbiology
Rank #60/182
Percentile 67.03
Quartile Q2

IF (Web Of Science)

INFECTIOUS DISEASES
Rank 26/132
Percentile 80.70
Quartile Q1
PHARMACOLOGY & PHARMACY
Rank 69/354
Percentile 80.60
Quartile Q1

JCI (Web Of Science)

INFECTIOUS DISEASES
Rank 29/132
Percentile 78.03
Quartile Q1
PHARMACOLOGY & PHARMACY
Rank 75/354
Percentile 78.81
Quartile Q1

Quartile History

Similar Journals

Malaysian Journal of Microbiology

Championing Innovation in Microbiology and Biotechnology
Publisher: MALAYSIAN SOC MICROBIOLOGYISSN: 1823-8262Frequency: 6 issues/year

Malaysian Journal of Microbiology is a prestigious open-access journal dedicated to advancing the field of microbiology, published by the Malaysian Society for Microbiology. Since its inception in 2005, this journal has become an essential platform for researchers and practitioners, facilitating the dissemination of innovative studies in applied microbiology, biotechnology, and infectious diseases. Based in Penang, Malaysia, this journal not only focuses on local microbiological research but also positions itself within the broader global scientific community. Although currently placed in the Q4 category in several relevant fields—including Applied Microbiology and Biotechnology, Infectious Diseases, and Medical Microbiology according to the 2023 Scopus rankings—it plays a crucial role in encouraging novel research and fostering collaboration among scientists. The journal encourages submissions that contribute to the understanding of microbial processes, disease mechanisms, and novel biotechnological applications, thereby supporting the continuous growth of knowledge in microbiology. With open access since its launch, the Malaysian Journal of Microbiology ensures that all published works are freely available to the public, enhancing their visibility and impact within the scientific community.

CRITICAL REVIEWS IN MICROBIOLOGY

Unveiling Insights, Shaping Microbiology's Future
Publisher: TAYLOR & FRANCIS LTDISSN: 1040-841XFrequency: 4 issues/year

CRITICAL REVIEWS IN MICROBIOLOGY, published by Taylor & Francis Ltd, is a leading peer-reviewed journal that has made significant contributions to the field of microbiology since its inception in 1971. With a prestigious Q1 ranking in Applied Microbiology and Biotechnology, as well as in Medicine and Microbiology, this journal is recognized for its high-quality reviews that synthesize current research and emerging trends in the discipline. Researchers and professionals rely on its comprehensive evaluations and critical insights, helping to advance knowledge and application in various microbiological contexts. Although the journal does not currently operate under an open access model, it remains an invaluable resource for academics seeking to stay at the forefront of microbiological advances. With a consistent publication record, CRITICAL REVIEWS IN MICROBIOLOGY continues to support the scholarly community by addressing key issues and innovations within the field.

ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Empowering Researchers to Combat Infectious Threats
Publisher: AMER SOC MICROBIOLOGYISSN: 0066-4804Frequency: 12 issues/year

Antimicrobial Agents and Chemotherapy, published by the American Society for Microbiology, is a leading journal in the fields of Infectious Diseases and Pharmacology. With a rich history dating back to its inception in 1963, this esteemed journal provides a vital platform for the dissemination of innovative research and advances in antimicrobials and therapeutic strategies. Currently holding a remarkable Q1 ranking in multiple categories, including Infectious Diseases and Pharmacology (medical), the journal occupies a prestigious position within its discipline, supported by exceptional rankings in Scopus metrics. As an essential resource for researchers, professionals, and students alike, it aims to foster knowledge exchange and inspire new strategies in combating infectious diseases. While not an open-access journal, it remains influential in shaping clinical applications and public health strategies through its rigorous peer-reviewed publications.

JOURNAL OF BIOMEDICAL SCIENCE

Fostering innovation in biochemistry and beyond.
Publisher: BMCISSN: 1021-7770Frequency: 1 issue/year

JOURNAL OF BIOMEDICAL SCIENCE, published by BMC, is a premier Open Access journal dedicated to the rapid dissemination of research in the fields of biomedical science, encompassing crucial areas such as biochemistry, cell biology, clinical biochemistry, and more. Since its inception in 1993, the journal has established itself as a leading publication, currently boasting a remarkable impact factor and quality as evidenced by its Q1 quartile rankings across multiple categories in 2023. With an impressive track record, including a Scopus ranking in the top percentiles across several disciplines, it serves as a vital resource for researchers, professionals, and students who are keen on advancing their knowledge in biomedicine. The journal operates under a fully Open Access model, ensuring that all published articles are freely available to the global research community, thus contributing to the broader dissemination and accessibility of scientific knowledge. Based in the United Kingdom, JOURNAL OF BIOMEDICAL SCIENCE is committed to fostering innovation and collaboration in research, appealing to those aiming to make impactful contributions to the biomedical sphere.

Journal of the Pediatric Infectious Diseases Society

Pioneering insights for a healthier tomorrow.
Publisher: OXFORD UNIV PRESSISSN: 2048-7193Frequency: 4 issues/year

Journal of the Pediatric Infectious Diseases Society, published by Oxford University Press, stands as a pivotal platform for advancing knowledge in the realm of pediatric infectious diseases. With an ISSN of 2048-7193 and an E-ISSN of 2048-7207, this esteemed journal has garnered significant recognition in the academic community, achieving influential rankings such as Q1 in Pediatrics, Perinatology and Child Health and Q2 in Infectious Diseases. With converged years from 2012 to 2024, it aims to publish cutting-edge research, reviews, and clinical practices that address the challenges and innovations in the field. The journal's strong performance, reflected in its Scopus ranks (33rd percentile in Pediatrics and 97th in Infectious Diseases), underscores its impact on the global healthcare landscape. As a non-open access journal, it provides exclusive content essential for researchers, medical professionals, and students dedicated to enhancing pediatric healthcare outcomes.

Lancet Microbe

Exploring Innovations in Infectious Diseases
Publisher: ELSEVIERISSN: Frequency: 12 issues/year

The Lancet Microbe is a leading peer-reviewed journal published by ELSEVIER, focused on advancing research in the fields of infectious diseases, microbiology, and virology. Since its inception in 2020, this open-access journal has rapidly achieved a prestigious reputation, evidenced by its impressive rankings in the Scopus Ranks, where it holds positions within the top 10 in multiple categories and boasts high percentiles, reflecting the impact and relevance of its published works. With a quarterly publication schedule, the Lancet Microbe aims to disseminate critical findings and foster innovation within the scientific community, providing a platform for researchers and professionals to share their significant contributions. The journal is committed to facilitating knowledge exchange and accessibility, making it an essential resource for academicians and practitioners dedicated to addressing global health challenges.

International Journal of Microbiology

Connecting Researchers Across Borders in Microbiology
Publisher: HINDAWI LTDISSN: 1687-918XFrequency: 1 issue/year

Welcome to the International Journal of Microbiology, a premier platform dedicated to the dissemination of cutting-edge research in the field of microbiology. Published by HINDAWI LTD, this open-access journal has been making significant strides since its inception in 2009, ensuring that high-quality research is accessible to all. Situated in Egypt, the journal caters to an international audience, fostering collaboration across borders. With a commendable impact factor and recognized in the Q2 category for both general and medical microbiology, it ranks 48th out of 182 and 40th out of 140, respectively, according to Scopus statistics, placing it among the top-tier journals in its field. The International Journal of Microbiology publishes articles that explore various aspects of microbiology, from fundamental studies to applied research, thus contributing significantly to advancements in medical, agricultural, and environmental microbiology. This journal is an essential resource for researchers, professionals, and students eager to stay at the forefront of microbiological studies and their applications.

JOURNAL OF CHEMOTHERAPY

Empowering Innovations in Oncology and Pharmacology
Publisher: TAYLOR & FRANCIS LTDISSN: 1120-009XFrequency: 6 issues/year

Journal of Chemotherapy is a distinguished peer-reviewed academic journal published by Taylor & Francis Ltd, focusing on the dynamic fields of infectious diseases, oncology, and pharmacology. With its ISSN 1120-009X and E-ISSN 1973-9478, this journal has been at the forefront of chemotherapy research since its inception in 1989 and continues to play a vital role in advancing medical science through rigorous studies and reviews. It currently holds a respectable position in various Scopus categories, ranked Q3 in several important disciplines, reflecting its commitment to providing quality research. Although it operates under a subscription model, Journal of Chemotherapy remains a crucial resource for practitioners and academics alike, facilitating knowledge exchange and innovation in the treatment of diseases through chemotherapy. With access to the latest findings and therapeutic advancements, this journal is a must-read for researchers, medical professionals, and students seeking to enhance their understanding of emerging trends in chemotherapy.

JOURNAL OF BASIC MICROBIOLOGY

Connecting Ideas in Microbiology and Biotechnology
Publisher: WILEYISSN: 0233-111XFrequency: 12 issues/year

JOURNAL OF BASIC MICROBIOLOGY is a premier publication in the field of microbiology, published by WILEY since 1985. With a significant presence in Germany, this journal encompasses a wide spectrum of research topics, focusing on applied microbiology and biotechnology as well as diverse areas within medicine. Holding a commendable Q2 ranking in both its categories for 2023, it plays a crucial role in disseminating innovative findings and methodologies to the community. Researchers will find it to be an essential platform for sharing high-quality work, where it currently stands at rank #47 in the applied microbiology and biotechnology category, representing the 63rd percentile among international journals. The JOURNAL OF BASIC MICROBIOLOGY caters to a growing audience of professionals and students, offering insights essential for advancement in microbiological research and its applications. While it does not currently offer an Open Access option, it remains an influential outlet for academic excellence, continuously contributing to the development of the field through its rigorous peer-reviewed articles.

Journal of Global Antimicrobial Resistance

Exploring the forefront of antimicrobial resistance research.
Publisher: ELSEVIER SCI LTDISSN: 2213-7165Frequency: 4 issues/year

The Journal of Global Antimicrobial Resistance, published by Elsevier Scientific Ltd, is a premier open access journal dedicated to addressing the critical issue of antimicrobial resistance on a global scale. Established in 2013 and significantly gaining traction as an open access platform since 2020, this journal serves as an essential resource for researchers, healthcare professionals, and policy makers invested in immunology, microbiology, and associated fields. With an impressive impact factor reflected through its consistent ranking in the Q2 category across multiple disciplines, including Microbiology and Immunology – where it ranks #29 out of 140 in Medical Microbiology – the journal ensures high-quality peer-reviewed articles that push the boundaries of current knowledge and practice. By offering a global perspective on research trends and public health implications, the Journal of Global Antimicrobial Resistance plays a pivotal role in advancing the scientific discourse necessary to combat the rising tide of antimicrobial resistance worldwide.